Learning Objectives:

1.    Describe relevant pathogenic mechanisms of pemphigus and pemphigoid
2.    Diagnose pemphigus and pemphigoid more effectively
3.    Develop treatment plans for pemphigus and pemphigoid with more confidence

 

Disclosures:

Donna Culton, MD, Presenter, is an Investigator on clinical trials for Principia Biopharma and Cabaletta Bio, and is a consultant for Argenx.

Faculty member does plan on discussing unlabeled/investigational uses of a commercial product: Methotrexate, mycophenolate, azathioprine, IVIg, omalizumab, dupilnmab

 

Session date: 
06/01/2022 - 9:00am to 11:00am EDT
Location: 
Boston University School of Medicine
United States
See map: Google Maps
Add to calendar: 
  • 2.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 Participation
Please login or register to take this course.